US Broker Ratings

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling a 12.82% Potential Upside Amid Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a pivotal player in the healthcare sector’s Diagnostics & Research industry, is garnering substantial attention from investors, thanks to its promising growth potential and robust..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 57% Potential Upside Amid Biotech Volatility

Moderna, Inc. (NASDAQ: MRNA) stands at the forefront of the biotechnology sector, known for its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, the company has garnered..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Growth Potential with a 22.9% Revenue Surge

Investors often seek companies with robust growth trajectories and innovative product offerings, and Globus Medical, Inc. (NYSE: GMED) certainly fits that profile. This healthcare giant, specializing in medical devices, is..

BioMarin Pharmaceutical Inc. (BMRN)

⚠️ No article content returned.

..

Novo Nordisk A/S (NVO) Stock Analysis: Impressive ROE and 17.75% Upside Potential

Novo Nordisk A/S (NYSE: NVO), a titan in the global healthcare sector, continues to capture investor attention with its robust performance metrics and strategic initiatives. Headquartered in Bagsvaerd, Denmark, the..

Illumina, Inc. (ILMN) Investor Outlook: Navigating a Complex Terrain with Strategic Insights

Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector specializing in diagnostics and research, has garnered significant attention from investors seeking exposure to genomic solutions. Based in San..

Molina Healthcare Inc (MOH): Investor Outlook with a 20% Potential Upside and Analyst Consensus

Molina Healthcare Inc (NYSE: MOH) stands at a pivotal juncture, drawing significant attention from investors intrigued by its robust growth potential and attractive valuation metrics. As a major player in..

argenx SE (ARGX) Stock Analysis: Unveiling a 4.57% Upside Potential with Strong Buy Ratings

argenx SE (ARGX), a prominent player in the biotechnology sector, is drawing significant attention from investors, not least due to its substantial market capitalization of $57.23 billion. Specializing in the..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 15.92% Potential Upside and Robust Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is drawing attention from investors with its compelling value proposition. With a market capitalization of $12.08 billion, Viatris operates..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Its 4.9% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a major player in the healthcare sector, has carved a niche in the medical distribution industry, offering an extensive range of products and services to..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling an 18% Potential Upside Amid Robust Analyst Ratings

In the dynamic landscape of the biotechnology industry, Royalty Pharma plc (NASDAQ: RPRX) stands out with its unique business model and promising growth prospects. With a market capitalization of $22.7..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 21.60% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, has piqued investor interest with its diversified operations across hospital and ambulatory care services. With a market..

Exelixis, Inc. (EXEL) Stock Analysis: Unpacking the 5.86% Potential Upside in Biotechnology

As investors navigate the dynamic landscape of biotech stocks, Exelixis, Inc. (NASDAQ: EXEL) commands attention with its robust market cap of $11.44 billion and a promising potential upside of 5.86%...

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 28.40% Upside in the Healthcare Tech Space

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector, where it operates as a premier provider of next-generation sequencing diagnostics and advanced molecular pathology testing. As..

AbbVie Inc. (ABBV) Investor Outlook: Navigating a Robust Market Cap with Potential Upside

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, commands a significant presence in the drug manufacturing industry. With a market capitalization of $417.6 billion, this biopharmaceutical giant continues..

Insmed Incorporated (INSM) Stock Analysis: Navigating Biotech Potential with a 7.73% Upside

Insmed Incorporated (NASDAQ: INSM), a notable player in the biotechnology sector, is capturing the attention of investors with its strategic focus on developing therapies for serious and rare diseases. Headquartered..

Encompass Health Corporation (EHC): Investor Outlook on a Robust 22.72% Potential Upside

Encompass Health Corporation (EHC), a leading player in the healthcare sector, continues to capture investor attention with its impressive growth metrics and robust analyst ratings. With a current market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: 23% Upside Potential Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, specializes in developing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders. With a market capitalization of $14.14 billion, this San..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Unpacking a 13% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with its impressive market cap of $109.42 billion and a robust portfolio targeting cystic fibrosis (CF) therapies. As a..

Danaher Corporation (DHR) Stock Analysis: Exploring an 11.79% Potential Upside Amidst Robust Buy Ratings

Danaher Corporation (NYSE: DHR) continues to capture the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a substantial market capitalization of $162.82 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds